Press releases

October 04, 2017

Bactiguard's central venous catheters approved in Hong Kong

The Hong Kong product approval for Bactiguard's central venous catheters for infection prevention has been announced by the Medical Device Control Office. Hong Kong is a small, but strategically important market, as it serves as a reference for new approvals and market acceptance in neighbouring China. 

September 28, 2017

New major order from China

Bactiguard has received a new order from China of 100 000 urinary catheters for infection prevention, which will be delivered in September and generate revenues of some 3 million SEK.

August 30, 2017

Bactiguard's central venous catheters approved in India

The product approval for Bactiguard's central venous catheters has been announced by the Indian Ministry of Health & Family Welfare. This provides new opportunities for Bactiguard in providing effective infection prevention in one of the largest and fastest growing markets in the world. 

August 28, 2017

Bactiguard appoints new CFO

Bactiguard Holding AB (publ) has appointed Cecilia Edström, today Senior Vice President Sales and New Business, as acting Chief Financial Officer (CFO). She succeeds Fredrik Järrsten, who will leave Bactiguard to assume a new CFO role in another company. Cecilia Edström will assume her new position on 15 September.

August 10, 2017

Interim report for Q2 2017

Bactiguard saves lives by preventing healthcare associated infections. With the development in the second quarter, sales of our own product portfolio have now increased for seven consecutive quarters, based on rolling twelve-month figures. This means that more patients have access to effective and safe infection prevention. The value of delivered products increased by approx. 76 %, due to higher volumes and improved product mix. Higher license revenues contribute considerably to the increase in total revenue compared with previous year. With continued cost control, EBITDA also improved and we reached an EBITDA margin of 11 %. Marketwise, the biggest breakthrough in the quarter was the tender we won in Stockholm. New partnerships were also established for Brazil, Italy and South Africa.

August 07, 2017

Invitation to presentation of Bactiguard's interim report on August 10, 2017

Bactiguard Holding AB (publ) publishes the interim report for the second quarter on Thursday, August 10, 2017 at 8:00 CET.

July 21, 2017

New Team Bactiguard

Good to Great Tennis Academy and Swedish medtech company Bactiguard AB have today announced that they are continuing to strengthen the development of future tennis talent in Sweden by focusing on younger players between 13 to 14 years of age. Together, Good to Great Tennis Academy and Bactiguard have created a new Team Bactiguard consisting of five promising tennis players in Sweden.

June 30, 2017

New major order from China

Bactiguard has received a third major order from China of 100 000 Bactiguard coated Foley catheters for infection prevention, which will be delivered in June and generate revenues of some 3 million SEK.

June 27, 2017

Bactiguard wins another tender in Sweden

Bactiguard has won a tender for urinary catheters for the southern region (Region Skåne) in Sweden, which enables healthcare providers in both primary and secondary care to purchase Bactiguards’ anti-infective urinary catheters from 1 August 2017. The contract initially runs until 30 April 2018 and can be extended on an annual basis until 30 April 2020. 

June 21, 2017

Bactiguard enters new partnership for South Africa

Bactiguard has entered partnership with Surgical Innovations Pty Ltd (“SI”), a company within the Medical arm of Ascendis Health, the JNB listed healthcare giant and leading supplier to the healthcare sector in South Africa. 

Pages

Subscribe